US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

38.25

+8.5828.92%

Post-market: 37.81-0.4400-1.15%18:27 EDT

Volume:389.00K

Turnover:14.37M

Market Cap:58.07M

PE:- -

High:39.10

Open:31.39

Low:31.39

Close:29.67

52wk High:152.22

52wk Low:11.52

Shares:1.52M

Float Shares:1.52M

Volume Ratio:2.46

T/O Rate:25.62%

Dividend:3.85

Dividend Rate:10.06%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

Short Report: Tempus AI short interest at record high

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

Tempus AI announces introduction of Tempus Preview

Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million

AI Application Software Shares Extended Gains. Palantir Up 10%; Salesforce And Rubrik Up 8%; Snowflake, GitLab And HubSpot Up 6%

Tiger Newspress

Tempus AI expects 25% top-line growth over next 3 years

Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B

Tempus AI announces initial results from Multimodal Foundation Model efforts

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune

Tempus AI posts investor day presentation on AI-driven diagnostics, precision-medicine data platform

Sector Update: Healthcare

MT Newswires Live

BUZZ-Tempus AI rises after securing FDA approval for tumor test

Tempus AI Shares up 7.3% Premarket After FDA Approves Its Xt Cdx Test for Genetic Profiling of Tumors

THOMSON REUTERS

Tempus wins FDA approval for tumor-only label on xT CDx genomic profiling test

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/TEMT/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TEMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEMT\",,,,,undefined,":{"symbol":"TEMT","market":"US","secType":"STK","nameCN":"Tradr 2X Long TEM Daily ETF","latestPrice":38.25,"timestamp":1789675200000,"preClose":29.67,"halted":0,"volume":388998,"hourTrading":{"tag":"盘后","latestPrice":37.81,"preClose":38.25,"latestTime":"18:27 EDT","volume":1084,"amount":41204.8996,"timestamp":1789684060523,"change":-0.44,"changeRate":-0.011503,"amplitude":0.021438},"delay":0,"changeRate":0.2891809908998988,"floatShares":1518300,"shares":1518300,"eps":0,"marketStatus":"Post-Mkt","change":8.58,"latestTime":"09-17 18:28:40 EDT","open":31.39,"high":39.1,"low":31.39,"amount":14365170.9927,"amplitude":0.259858,"askPrice":38.1,"askSize":400,"bidPrice":37.44,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":29.67,"sharesOutstanding":4440000,"nav":28.6792,"aum":43544099.99,"dividendRate":0.100607,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31.6503,"preClose":29.67,"latestTime":"09:29 EDT","volume":2526,"amount":78772.21119,"timestamp":1789651771907,"change":1.9803,"changeRate":0.066744,"amplitude":0.060667},"postHourTrading":{"tag":"盘后","latestPrice":37.81,"preClose":38.25,"latestTime":"18:27 EDT","volume":1084,"amount":41204.8996,"timestamp":1789684060523,"change":-0.44,"changeRate":-0.011503,"amplitude":0.021438},"volumeRatio":2.463157,"impliedVol":1.4467,"impliedVolPercentile":0.6787},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEMT\",,,,,undefined,":{"symbol":"TEMT","floatShares":1518300,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.463157,"shares":1518300,"dividePrice":3.8482,"high":39.1,"amplitude":0.259858,"preClose":29.67,"low":31.39,"week52Low":11.52,"pbRate":"--","week52High":152.22,"institutionHeld":0,"latestPrice":38.25,"eps":0,"divideRate":0.100607,"volume":388998,"delay":0,"ttmEps":0,"open":31.39,"prevYearClose":34.35,"prevWeekClose":21.35,"prevMonthClose":24.63,"prevQuarterClose":24.56,"fiveDayClose":21.1,"twentyDayClose":24.1501,"sixtyDayClose":17.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEMT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"TEMT","defaultRemindTime":1773149400000,"type":"split","dateTimestamp":1773115200000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-12-23","symbol":"TEMT","amount":3.84752,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"2倍做多TEM ETF-Tradr","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEMT\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-26","value":3.84752,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TEMT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEMT\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640951441","title":"Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951441?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:33","pubTimestamp":1780317227,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290HM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","TEM","TEMT","LU1861559042.SGD","LU1861558580.USD","BK4611","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959423","title":"Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959423?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:59","pubTimestamp":1780315153,"startTime":"0","endTime":"0","summary":"In a report released today, Subbu Nambi from Guggenheim maintained a Buy rating on Tempus AI, Inc. Class A, with a price target of $60.00. Nambi co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4611","BK4121","TEM","BK4613","TEMT","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640881955","title":"Tempus AI Price Target Maintained With a $80.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2640881955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640881955?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:44","pubTimestamp":1780310640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 06:44 ET (10:44 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861558580.USD","TEM","TEMT","BK4613","LU1861559042.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640893728","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640893728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640893728?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:20","pubTimestamp":1780305650,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-tempus-ai-inc-class-a-tem-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-tempus-ai-inc-class-a-tem-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689472784.USD","LU0471298777.SGD","LU0882574055.USD","LU2237443549.SGD","LU2417539215.USD","LU2756315664.SGD","LU2108987350.USD","LU2491049909.HKD","LU2023251221.USD","LU1035775433.USD","IE00BFSS7M15.SGD","LU0353189763.USD","LU0823434740.USD","LU2168564495.EUR","LU0256863811.USD","LU1988902786.USD","LU2265009873.SGD","BK4139","LU1366192091.USD","IE0004445239.USD","LU0058720904.USD","IE00BK4W5L77.USD","LU1917777945.USD","IE00B4R5TH58.HKD","LU1720051017.SGD","SG9999017495.SGD","BK4599","ELIS","IE00B775H168.HKD","LU1323610961.USD","IE00BKDWB100.SGD","LU0417517546.SGD","LU2468319806.SGD","LU1868837136.USD","LU2168564065.EUR","LU0122379950.USD","LU2106854487.HKD","LU2237443465.HKD","SG9999018865.SGD","LU0198837287.USD","LU0109394709.USD","LU0210536198.USD","LU2089284900.SGD","LU0385154629.USD","LU0158827781.USD","LU2357305700.SGD","LU0708995401.HKD","LU1061106388.HKD","LLYX","LU0158827948.USD","LU0266013472.USD","LU2746668461.USD","LU1145028129.USD","IE0001KFT4U8.USD","BK4611","LU1861558580.USD","LU2237443978.SGD","LU2361044865.SGD","LU1868836914.USD","IE00B1XK9C88.USD","LU0097036916.USD","IE0009355771.USD","LU0323591593.USD","SG9999014880.SGD","LU0640476718.USD","LU0820561909.HKD","LU0289739699.SGD","LU2750360997.AUD","LU0320765992.SGD","SG9999015986.USD","LU0672654240.SGD","LU0061475181.USD","IE00BFSS8Q28.SGD","TEM","LU0096364046.USD","LU1267930730.SGD","BK4550","LU1720051108.HKD","BK4516","SG9999001176.USD","LU0203201768.USD","LU0432979614.USD","IE0004445015.USD","LU2063271972.USD","LU0353189680.USD","LU0354030511.USD","SG9999001176.SGD","LU1623119135.USD","LU2361045086.USD","LU0471298694.HKD","IE00BN29S564.USD","LU2237443382.USD","SG9999014898.SGD","LU1804176565.USD","LU2360106947.USD","LLY","SGXZ81514606.USD","LU2491050071.SGD","LU2456880835.USD","LU2552382058.USD","LU0079474960.USD","LU2087625088.SGD","SGXZ99366536.SGD","LU2237438978.USD","IE00BKPKM429.USD","LU1629891620.HKD","LU0320765059.SGD","SG9999015978.USD","LU0316494557.USD","LU1989771016.USD","LU0786609619.USD","LLYZ","LU2471134952.CNY","LU0466842654.USD","BK4007","IE00BJJMRX11.SGD","IE0005OL40V9.USD","IE0002141913.USD","SG9999014914.USD","LU1974910355.USD","SG9999018857.SGD","LU2361044949.HKD","LU2552382215.SGD","SG9999015952.SGD","LU2028103732.USD","ELIL","SGXZ57979304.SGD","BK4585","LU1064131342.USD","LU1069344957.HKD","LU1057294990.SGD","LU2213496289.HKD","LU0456855351.SGD","LU0234572021.USD","LU1551013425.SGD","BK4613","IE00BFTCPJ56.SGD","LU0882574139.USD","LU2491050154.USD","LU0114720955.EUR","LU2471134796.USD","LU1548497426.USD","LU0889565916.HKD","LU0006306889.USD","LU0823416689.USD","LU2461242641.AUD","LU2471134523.USD","IE00BJJMRY28.SGD","BK4121","IE00B4JS1V06.HKD","LU2746668974.SGD","LU2552382132.HKD","LU0683600562.USD","LU0787776722.HKD","LU2023250504.SGD","LU2271345857.HKD","LU0943347566.SGD","SGXZ51526630.SGD","LU2750360641.GBP","LU0820561818.USD","LU2236285917.USD","LU1551013342.USD","LU1712237335.SGD","LU2756315318.SGD","LU0820562030.AUD","LU0094547139.USD","LU0109391861.USD","LU1280957306.USD","LU1868836591.USD","LU1023059063.AUD","TEMT","IE00BWXC8680.SGD","LU2089283258.USD","BK4533","SG9999014906.USD","BK4581","LU2168564222.USD","LU2264538146.SGD","SG9999013999.USD","LU2896262040.SGD","LU2211815571.USD","LU2237443895.HKD","LU2462157665.USD","LU0823434583.USD","LU2023250330.USD","LU1868836757.USD","INCY","LU0256863902.USD","LU0133085943.USD","IE00B7KXQ091.USD","SGXZ31699556.SGD","LU0225283273.USD","LU2237443622.USD","LU0238689110.USD","LU0106261372.USD","LU2089984988.USD","GB00BDT5M118.USD","BK4588","IE00BJT1NW94.SGD","IE00BJLML261.HKD","LU1093756168.USD","BK4532","IE00B1BXHZ80.USD","LU0203202063.USD","LU1232071149.USD","LU1814569148.SGD","LU1127390331.HKD","LU2112291526.USD","LU1868837300.USD","SG9999015945.SGD","IE00B2B36J28.USD","LU2602419157.SGD","LU2471134879.HKD","LU0964807845.USD","LU1861559042.SGD","LU2111349929.HKD","IE00BJJMRZ35.SGD","BK4534","LLII","LU0354030438.USD","LU1093756325.SGD","LU2168564149.EUR","LU1291159041.SGD","LU2168563687.JPY","LU2324357040.USD","LU1983299246.USD","IE00BK4W5M84.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640934707","title":"Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2640934707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640934707?lang=en_us&edition=fundamental","pubTime":"2026-06-01 16:35","pubTimestamp":1780302955,"startTime":"0","endTime":"0","summary":"Tempus AI  has introduced the next-generation of its agentic AI platform for oncology drug development, Lens, the company said over the weekend.The platform was designed to help drug development teams to design better clinical trials, target patient subgroups, and generate evidence more quickly, Tempus AI said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","BK4613","BK4121","LU1861559042.SGD","LU1861558580.USD","TEMT","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640849739","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640849739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640849739?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:20","pubTimestamp":1780276807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-krystal-biotech-krys-abbvie-abbv-and-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-krystal-biotech-krys-abbvie-abbv-and-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU1057294990.SGD","LU0310799852.SGD","LU0124676726.USD","LU0211327993.USD","LU0057025933.USD","LU0689626769.HKD","LU2237443549.SGD","LU2237443622.USD","SG9999015978.USD","LU0661504455.SGD","TEMT","LU0456855351.SGD","LU1496350502.SGD","LU2237443465.HKD","BK4611","ABBV","IE0002141913.USD","IE00BLSP4239.USD","LU1989771016.USD","LU0289739343.SGD","LU1003077747.HKD","LU1496350171.SGD","IE00B19Z3581.USD","SG9999011175.SGD","LU0170899867.USD","LU0985320562.USD","IE00B3PB1722.GBP","LU2468319806.SGD","LU0098860793.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU1839511570.USD","BK4550","LU1244550221.USD","KRYS","BK4559","LU1989772923.USD","LU1074936037.SGD","IE00BDGV0183.EUR","LU1551013342.USD","LU2089984988.USD","SG9999003800.SGD","LU0472753341.HKD","LU2357627491.SGD","LU0203345920.USD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU2129689605.HKD","LU0689472784.USD","LU1934455863.HKD","SG9999015952.SGD","LU0234570918.USD","LU0820561818.USD","LU0738911758.USD","LU0965509101.SGD","LU0234572021.USD","IE00BVYPNW00.USD","LU1267930490.SGD","BK4534","LU0122379950.USD","LU2087621335.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1929549753.HKD","LU0795875086.SGD","LU0203347892.USD","IE00BJJMRZ35.SGD","BK4613","IE0004445239.USD","SG9999015986.USD","LU0198837287.USD","LU1244550494.USD","BK4581","LU0868494708.USD","LU2347655156.SGD","LU1989772840.SGD","IE0002270589.USD","BK4566","IE000WAW04H5.SGD","LU0256863811.USD","LU1934455194.USD","IE00BVYPNV92.GBP","LU1861559042.SGD","LU1267930573.SGD","LU1732799900.SGD","LU2089284900.SGD","IE00B42XCP33.USD","LU1093756325.SGD","LU0859254822.USD","LU2129689431.USD","LU1430594728.SGD","LU1718418525.SGD","LU0114720955.EUR","LU1732800096.USD","LU1861558580.USD","LU1585245621.USD","BK4139","LU1093756168.USD","LU0943347566.SGD","LU1670627923.USD","LU0868494617.USD","LU0553294199.USD","LU0128525929.USD","LU0289961442.SGD","LU2237443978.SGD","IE00BLSP4452.SGD","LU0029864427.USD","LU0708994859.HKD","LU1934455277.USD","LU1670628061.USD","IE0000B7K699.USD","LU0511384066.AUD","LU2237443895.HKD","IE000F7OJYX1.SGD","LU0942090050.USD","LU0965509010.AUD","LU0417517546.SGD","IE00BGHQF631.EUR","LU1162221912.USD","LU0795875169.SGD","IE00B2B36J28.USD","LU0861579265.USD","LU0320765646.SGD","LU0949170772.SGD","LU0965509283.SGD","BK4121","LU0965508806.USD","LU0211328371.USD","IE000BZT7R73.USD","LU0912757837.SGD","IE000MB6IJN5.SGD","LU0823416689.USD","IE00BFTCPJ56.SGD","IE000SO60NU8.SGD","LU0256863902.USD","LU2237443382.USD","LU0310800379.SGD","LU1291159041.SGD","LU2133065610.SGD","LU0069063385.USD","BK4588","TEM","LU1037948541.HKD","SG9999015945.SGD","LU2089283258.USD","LU1023059063.AUD","BK4585","LU2129689514.USD","LU0820561909.HKD","LU1983299246.USD","LU0058720904.USD","LU2023251221.USD","LU1061106388.HKD","SG9999001440.SGD","LU1551013425.SGD","LU2112291526.USD","IE00BSNM7G36.USD","LU0545039389.USD","LU1037948897.HKD","LU0158827948.USD","LU1244550577.SGD","LU0432979614.USD","LU0882574055.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640625986","title":"Short Report: Tempus AI short interest at record high","url":"https://stock-news.laohu8.com/highlight/detail?id=2640625986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640625986?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:05","pubTimestamp":1780261557,"startTime":"0","endTime":"0","summary":"Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most widely f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/short-report-tempus-ai-short-interest-at-record-high-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/short-report-tempus-ai-short-interest-at-record-high-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","TEM","LU1861559042.SGD","BK4121","BK4613","LU1861558580.USD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988179","title":"Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988179?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:35","pubTimestamp":1780234504,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced the launch of the PRECISION Challenge, an initiative engineered to accelerate the next generation of oncology breakthroug...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-launch-of-precision-challenge-for-oncology-breakthroughs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-launch-of-precision-challenge-for-oncology-breakthroughs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4613","TEM","BK4611","BK4121","TEMT","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988109","title":"Tempus AI announces introduction of Tempus Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988109?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:25","pubTimestamp":1780233904,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced the introduction of Tempus Preview. “Tempus Preview offers preliminary results in the critical window between when a diag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-introduction-of-tempus-preview-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-introduction-of-tempus-preview-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","TEMT","BK4121","TEM","LU1861558580.USD","LU1861559042.SGD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639057672","title":"Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639057672","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639057672?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:16","pubTimestamp":1780085770,"startTime":"0","endTime":"0","summary":"Shares sold at weighted average prices of USD 46.17 and USD 46.89.Holdings reported via Gray Media fell to 8,808,533 shares; holdings via Blue Media fell to 15,523,469 shares.Lefkofsky also reported 2,230,721 shares held directly following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL6mnXQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861558580.USD","BK4121","TEM","LU1861559042.SGD","BK4613","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113445541","title":"AI Application Software Shares Extended Gains. Palantir Up 10%; Salesforce And Rubrik Up 8%; Snowflake, GitLab And HubSpot Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113445541","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113445541?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:37","pubTimestamp":1780065450,"startTime":"0","endTime":"0","summary":"AI Application Software Shares Shined. BigBear.ai Up 10%; Tempus Up 7%; SoundHound Up 6%; Palantir Up 3%; MongoDB, GitLab, C3.ai And Salesforce Up 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPSX","ADBE","PLOO","PLTU","DUOG","PLTD","LMNX","APP","NOWL","UNX","DOGD","PLTY","RDTL","CRNC","BBAI","SOUN","TEAM","CRMG","PLTR","TEM","U","AIYY","PLTZ","APPX","FIGG","TTDU","BRZE","RDDT","LMND","BAIG","ADBG","RBRK","PLTG","UPST","RDYY","DUOL","TEMT","GTLB","DDOG","HUBS","AI","RZLV","PLTI","PTIR","CRM","PLYY","NOW","PLTA","SOUX","PLTW","TTD","ADP","FIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639755586","title":"Tempus AI expects 25% top-line growth over next 3 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2639755586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639755586?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:36","pubTimestamp":1780065386,"startTime":"0","endTime":"0","summary":"In investor presentation slides, Tempus AI (TEM) stated: “We expect 25% top-line growth over the next 3 years supported by continued strength in Di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-expects-25-top-line-growth-over-next-3-years-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-expects-25-top-line-growth-over-next-3-years-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","TEMT","TEM","BK4613","BK4121","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639675542","title":"Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B","url":"https://stock-news.laohu8.com/highlight/detail?id=2639675542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639675542?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:35","pubTimestamp":1780065302,"startTime":"0","endTime":"0","summary":"Reiterates FY26 adjusted EBITDA view of roughly $65M. Guidance from investor day slides. Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-reiterates-fy26-revenue-view-of-1-59b-1-6b-consensus-1-59b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-reiterates-fy26-revenue-view-of-1-59b-1-6b-consensus-1-59b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","TEMT","TEM","BK4613","BK4121","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639678195","title":"Tempus AI announces initial results from Multimodal Foundation Model efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2639678195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639678195?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:35","pubTimestamp":1780061750,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncolo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-initial-results-from-multimodal-foundation-model-efforts-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-initial-results-from-multimodal-foundation-model-efforts-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4121","TEM","LU1861559042.SGD","BK4611","BK4613","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620012","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620012?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:21","pubTimestamp":1780060878,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL6N4260OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","BK4550","BK4543","LU2065170008.USD","LU2210150020.SGD","BK4602","LU0265550946.USD","LU0471298777.SGD","BK4187","AGIO","DELL","LU0823434740.USD","BK4533","LU2125909247.SGD","LU2210149790.SGD","LU1267930227.SGD","IE00B5TLWC47.USD","LU0823434583.USD","BK4139","BK4613","LU1116320901.HKD","BK4535","IE0008368304.USD","LU1551013425.SGD","HK0000819398.USD","LU0310800965.SGD","BK4504","LU1506573853.SGD","LUNL","BK4121","LU2168564149.EUR","AEO","COST","LU0256863811.USD","FLY","LU0385154629.USD","BK4515","LU0128525689.USD","BK4581","LU2065171311.SGD","LU0267386448.USD","LU0211326755.USD","LU1571399168.USD","LU2125909593.SGD","LU1066051498.USD","LU1496350502.SGD","LU1323610961.USD","LU1069344957.HKD","LU2433249047.HKD","BK4615","BK4611","IE00BKVL7J92.USD","LU0211326839.USD","RKLX","LU2097829019.USD","BK4561","BK4094","LU0079474960.USD","LU0943347566.SGD","GAP","LU0238689110.USD","LU0820561818.USD","LU1066051811.HKD","LU0234570918.USD","LU1551013342.USD","PLU","LU2168564065.EUR","KRMN","UFO","LU0471298694.HKD","IFF","REPL","BK4155","RKLB","TEMT","LU1923622614.USD","LU1823568750.SGD","LU0820561909.HKD","LU0048573561.USD","MWH","FPS","LU0689472784.USD","LU2065169927.USD","COSW","BK4588","LU0417517546.SGD","RKLZ","LU0052756011.USD","LU0976567544.SGD","LU1861559042.SGD","LU2168564222.USD","LU2065171402.SGD","LU0742534661.SGD","LU0234572021.USD","PL","LU0251142724.SGD","LU1861558580.USD","LU1235294995.USD","TEM","BK4182","LU0496365809.HKD","LU0985320562.USD","BK4596","LU2237438978.USD","DLLL","BK4109","LU2125154778.USD","LU2360032135.SGD","BK4585","LU0251131958.USD","FLYT","LU2360106947.USD","LU2381873111.SGD","LU1496350171.SGD","LU0265550359.USD","LU1066051225.USD","LU1046421795.USD","LU2168563687.JPY","LU2168564495.EUR","LU1116320737.USD","IE00BZ1G4Q59.USD","COTG","LU2125154935.USD","LU2095319765.USD","BK4564","LU0314106906.USD","LU1066053197.SGD","LUNR","BK4123","BK4170","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620102","title":"Tempus AI posts investor day presentation on AI-driven diagnostics, precision-medicine data platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620102","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620102?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:05","pubTimestamp":1780059957,"startTime":"0","endTime":"0","summary":"Tempus AI outlined a strategy to pair AI-enabled diagnostics with embedded clinical distribution to scale precision medicine across care and drug development.Operating metrics as of 3/31/2026: ~65% of US academic medical systems connected, >55% of US oncologists reached, 5,000+ institutions.Data scale as of 3/31/2026: 500+PB multimodal dataset, >45 million de-identified patient records, >4.5 million samples sequenced.Diagnostics throughput as of 3/31/2026: ~1 million NGS tests run annually across four labs, ~4,000 employees.Clinical evidence highlights: DNA+RNA sequencing identified 21% more patients with driver fusions tied to FDA-approved targeted therapies versus DNA alone.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLy2cL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","BK4121","LU1861558580.USD","BK4613","BK4611","LU1861559042.SGD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639062036","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2639062036","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639062036?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:57","pubTimestamp":1780059476,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  down 0.1% and the iShares Biotechnology ETF  0.1% higher.Tempus AI  shares were up more than 7% after the company said it has received approval from the US Food and Drug Administration for a tumor-only indication for its xT CDx next-generation sequencing platform used for comprehensive genomic profiling of solid tumors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4611","LU1861558580.USD","BK4585","IBB","LU1861559042.SGD","TEM","XBI","BK4121","BK4613","XLV","TEMT","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639483627","title":"BUZZ-Tempus AI rises after securing FDA approval for tumor test","url":"https://stock-news.laohu8.com/highlight/detail?id=2639483627","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639483627?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:33","pubTimestamp":1780057994,"startTime":"0","endTime":"0","summary":"BUZZ-Tempus AI rises after securing FDA approval for tumor test** Shares of AI-enabled precision medicine firm Tempus AI TEM.O rise 7.2% to $55.07 premarket** Co says U.S. FDA approved its diagnostic tool, xT CDx, for genetic profiling of solid tumors to help doctors identify which therapies will work best for the patient** The test is designed to detect genetic alterations without requiring a matching normal saliva or blood sample from the patient** xT CDx is also approved as a companion diagnostic tool to identify colorectal cancer patients who may benefit from targeted therapies** Up to last close, stock down 13.1% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N42614C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4611","BK4613","LU1861558580.USD","TEM","LU1861559042.SGD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639276456","title":"Tempus AI Shares up 7.3% Premarket After FDA Approves Its Xt Cdx Test for Genetic Profiling of Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2639276456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639276456?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:27","pubTimestamp":1780057676,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N42614A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","BK4121","TEM","LU1861559042.SGD","BK4611","LU1861558580.USD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639828627","title":"Tempus wins FDA approval for tumor-only label on xT CDx genomic profiling test","url":"https://stock-news.laohu8.com/highlight/detail?id=2639828627","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639828627?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:16","pubTimestamp":1780056976,"startTime":"0","endTime":"0","summary":"FDA granted a tumor-only indication for Tempus xT CDx, expanding its companion diagnostic label to cover tumor-only genomic profiling.Decision enables migration of its DNA solid tumor testing portfolio to FDA-cleared assays under unified ADLT pricing.Tempus expects an estimated $200 average selling price uplift starting in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8y90pp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861558580.USD","LU1861559042.SGD","TEMT","BK4121","BK4613","TEM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}